• About Us
  • Copyright Policy
  • Disclaimer
  • Authors
  • Career
  • Contact Us
Assamese |   Bengali |  
Thursday, January 28, 2021
NORTHEAST NOW
  • HOME
  • NORTH EAST
    • Assam
    • Meghalaya
    • Tripura
    • Mizoram
    • Manipur
    • Nagaland
    • Arunachal
    • Sikkim
  • Neighbours
    • Nepal
    • Bhutan
    • China
    • Myanmar
    • Bangladesh
  • Business
  • Entertainment
  • Sports
  • Environment
  • Citizen Journalists
  • Opinion
No Result
View All Result
  • HOME
  • NORTH EAST
    • Assam
    • Meghalaya
    • Tripura
    • Mizoram
    • Manipur
    • Nagaland
    • Arunachal
    • Sikkim
  • Neighbours
    • Nepal
    • Bhutan
    • China
    • Myanmar
    • Bangladesh
  • Business
  • Entertainment
  • Sports
  • Environment
  • Citizen Journalists
  • Opinion
No Result
View All Result
NORTHEAST NOW
Assamese
Home Health

Illegal cancer drugs from Bangladesh invade Indian market

NE NOW NEWS by NE NOW NEWS
GUWAHATI , November 18, 2019 4:11 pm
Illegal cancer drugs from Bangladesh

Representational image

Share on FacebookShare on Twitter

Not just raw materials (active pharmaceutical ingredients) from China, but illegally imported cancer drugs from Bangladesh is flooding the Indian market.

This invasion is giving sleepless night to the Indian pharma companies who see this as a threat, not just to the revenue but most importantly to the lives of the patients.

A recent study has confirmed a mushrooming grey market of fake and unapproved oncology and hepatology medicines of popular pharma companies.

“Since these medicines are smuggled, mostly from Bangladesh, its exact number cannot be ascertained,” the study said.

“However, as per company experts’ view this grey market could be over Rs 300 crore for just oncology drugs,” the study added.

“Domestic companies and MNCs, which manufacture these medicines, suffer potential losses due to the cheaper fakes,” Times of India reported.

“About 12 per cent of those prescribed these medications could be consuming fake tablets/capsules, according to oncologists,” the report added.

The report further said as these medicines are not imported legally hence their safety and efficiency is not known.

“Moreover, there are no records of clinical trials of these medicines and they do not have drug controller’s approvals,” the study added.

The matter was recently discussed by the Organisation of Pharmaceutical Producers of India (OPPI) with Centre and the member companies were assured that steps would be taken soon.

Experts are of the view that since most of the medicines are manufactured and imported illegally from Bangladesh, hence the Indo-Bangla border must be strengthened and prevent illegal entry of these medicines.

They are also of the view that the pharma companies should educate both doctors and patients about these cheap and fake medicines.

TikTok

Ban impact: TikTok scales down India operation

flood

Only adaptive capacity can reduce flood miseries in Assam: NGO

Goalpara DC

Assam: Goalpara DC launches Jal Shakti ministry programme ‘Catch the Rain’

3 ULFA(I) cadres

Assam Rifles personnel nab 3 ULFA(I) cadres in Arunachal Pradesh’s Tirap district   

NORTHEAST NOW

Northeast Now is a multi-app based hyper-regional bilingual news portal. Led by a group of professionals, the digital news platform covers every inch of the eight states of northeast India and the five neighbouring countries. It is the first of its kind new media initiative in the northeast, and is based in Guwahati. As the political dynamics in the northeast is intricate and fluid, Northeast Now is always politically neutral.

 
Our Properties
 
  • NORTHEAST NOW ASSAMESE
  • NORTHEAST JOBS
  • NORTHEAST TENDERS
  • INNFINITY
  • About Us
  • Copyright Policy
  • Disclaimer
  • Authors
  • Career
  • Contact Us

© 2019 - Maintained by EZEN Software & Technology Pvt. Ltd

No Result
View All Result
  • HOME
  • NORTH EAST
    • Assam
    • Meghalaya
    • Tripura
    • Mizoram
    • Manipur
    • Nagaland
    • Arunachal
    • Sikkim
  • Neighbours
    • Nepal
    • Bhutan
    • China
    • Myanmar
    • Bangladesh
  • Business
  • Entertainment
  • Sports
  • Environment
  • Citizen Journalists
  • Opinion

© 2019 - Maintained by EZEN Software & Technology Pvt. Ltd